Arca
Skip to content
Tools
Tools

-zomib

A proteasome inhibitor, jamming the machinery cells use to break down proteins; used in multiple myeloma.

  • Drugs ending in -zomib: 9
  • Approved somewhere: 4
  • With a US drug page: 4

What it means

Stem from WHO's stem book, 2024; description by Arca
Stem
-zomib
Class
Cancer drugs that jam the proteasome, like bortezomib
Most common targets
26S proteasome (5), 20S proteasome (1)

Drugs that carry it

Approved and clinical-stage drugs in ChEMBL whose names ending in -zomib, matched by spelling; those with a US drug page link to it.
Acts on
BortezomibApproved26S proteasome26S proteasome inhibitor
CarfilzomibApproved26S proteasome26S proteasome inhibitor
IxazomibApproved26S proteasome26S proteasome inhibitor
Ixazomib citrateApproved26S proteasome26S proteasome inhibitor
MarizomibPhase 320S proteasome20S proteasome inhibitor
DavelizomibPhase 2——
ZetomipzomibPhase 2——
DelanzomibPhase 1——
OprozomibPhase 126S proteasome26S proteasome inhibitor

Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.